Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2000

View Archived Issues

Extensive review of novel cytoprotectant appears in supplementary issue of DOT

NCI initiates third phase II trial of O6-benzylguanine in combination with BCNU

Pharming and Baxter to jointly develop treatment for hereditary angioedema

Carrington Laboratories discontinues development of Aliminase due to disappointing phase III results

Incyte Pharmaceuticals to change name to Incyte Genomics

Merck & Co. confirms study results of Singulair as allergic rhinitis treatment

Oxford BioMedica enters agreement with Nycomed Amersham for tumor imaging

Novel CRF antagonists under study at DuPont

3-Dimensional Pharmaceuticals begins clinical testing of oral thrombin inhibitor

New metabotropic glutamate receptor agonists for psychiatric, neurological disorders

Positive preliminary results reported for Enzo's phase I trial of EHT-899

UCB's new muscarinic agents useful for pain, schizophrenia and Alzheimer's disease

New series from SB interacts with signal transduction to inhibit inflammation

Novel gastric antisecretory agents designed by AstraZeneca scientists

Kinetek validates ILK inhibition as potential cancer therapy

BMS patents new antibacterial series useful against resistant infections

Highly potent and orally bioavailable nonbenzamidine factor Xa inhibitors presented to ACS

Cangene begins pivotal HBV study, terminates agreement with Octapharma

ACS news: BMS presents potent new inhibitor of cyclin-dependent kinases

SR-10204 and SR-10208 identified as potent anti-HCMV agents

Discovery of ischemia-selective NMDA antagonists reported at ACS by Cambridge NeuroScience

Salix receives FDA approvable letter for balsalazide disodium

Two studies presented in Yokohama explore effects of GA-0113 in pulmonary hypertension

The FDA approves Zonegran for the treatment of epilepsy

TRK-820 demonstrates kappa-receptor-mediated antipruritic effects in animal model

FK-960, a novel antidementia agent in phase II, increases synapse density in aged rats

New farnesyltransferase inhibitor L-779575 presented by Merck this week

R.W. Johnson presents R&D on nicotinic acetylcholine receptor ligands

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...